KAUST ·
KAUST Health annually celebrates World Health Day, with the 2018 theme focused on wellness. The event included activities like a Masterchef competition, nutrition advice, wellness quizzes, and skin care tips. BUPA presented its Tebtom Program aimed at holistic healthcare for the KAUST community. Why it matters: Such initiatives at GCC universities raise awareness of preventative health and wellness, contributing to healthier lifestyles and community well-being.
MBZUAI ·
This research introduces a novel method using the Lateral Accretive Hybrid Network (LEARNet) to capture and analyze micro-expressions for mental health applications. The method refines both broad and subtle facial cues to detect mental health conditions like anxiety or depression. The authors also propose a neural architecture search (NAS) strategy to design a compact CNN for micro-expression recognition, improving performance and resource use. Why it matters: By integrating micro-emotion recognition with mental health estimation, the approach enables more accurate and early detection of emotional and mental health issues, potentially leading to improved well-being.
MBZUAI ·
MBZUAI researchers developed FetalCLIP, an AI model trained on 210,000 ultrasound images for fast and reliable interpretation of fetal scans. MBZUAI's President Eric Xing contributed to the General Expression Transformer (GET), an AI foundation model acting as a biological simulator to predict gene behavior. MBZUAI and Carleton University created MedPromptX for quicker disease diagnosis and treatment plans using multimodal AI. Why it matters: These AI advancements from MBZUAI have the potential to revolutionize healthcare in the region and globally, from prenatal care to drug discovery and personalized medicine.
KAUST ·
KAUST and the SFDA co-hosted the "Trends in Microbiome and Digital One Health" conference from October 30 to November 1, 2023, featuring 35 speakers from five continents. Discussions centered on microbiome science, digital tools for tracking microbial epidemiology, and their roles in the One Health concept. The conference facilitated the formation of a consortium for microbiome and Digital One Health research. Why it matters: This event highlights Saudi Arabia's growing focus on leveraging microbiome research and digital technologies to address public health challenges and promote international collaboration in the field.
MBZUAI ·
MBZUAI hosted a two-day workshop on "Big Model AI in Drug Design" starting February 20, 2023. The workshop featured presentations from researchers in public and private institutions working on AI and health. MBZUAI Adjunct Professor Eran Segal opened the workshop with a talk on the Human Phenotype Project. Why it matters: The event highlights the growing interest and activity in applying AI, particularly large models, to advance drug discovery and personalized medicine within the UAE's research ecosystem.
MBZUAI ·
Eran Segal from Weizmann Institute of Science presented The Human Phenotype Project, a large-scale prospective cohort with over 10,000 participants. The project aims to identify novel molecular markers and develop prediction models for disease onset using deep profiling. The profiling includes medical history, lifestyle, blood tests, and molecular profiling of the transcriptome, genetics, microbiome, metabolome and immune system. Why it matters: Such projects demonstrate the growing focus on personalized medicine in the region, utilizing advanced AI and machine learning techniques for disease prevention and treatment.
MBZUAI ·
Professor Eran Segal presented The Human Phenotype Project, a longitudinal cohort study with over 10,000 participants. The project aims to identify molecular markers and develop prediction models for disease using deep profiling techniques including medical history, lifestyle, blood tests, and microbiome analysis. The study provides insights into drivers of obesity, diabetes, and heart disease, identifying novel markers at the microbiome, metabolite, and immune system level. Why it matters: Such large-scale phenotyping initiatives could inform personalized medicine approaches relevant to the Middle East's specific health challenges.
KAUST ·
Saudi health innovators are increasing investment in smart health solutions, using KAUST's infrastructure and expertise. The King Salman Center for Disability Research (KSCDR) and KCSH are partnering on AI-based methods to identify genetic causes of rare eye diseases. KAUST and the Saudi Food and Drug Administration (SFDA) are expanding their agreement to enhance cooperation on AI and digital innovation. Why it matters: These partnerships signal a concerted effort to leverage AI for addressing critical healthcare challenges and advancing the Kingdom's health priorities.